Monitoring of Specific Birth Defects Associated With Exposure to Lamotrigine in Pregnancy Through the EUROCAT Network.

Trial Profile

Monitoring of Specific Birth Defects Associated With Exposure to Lamotrigine in Pregnancy Through the EUROCAT Network.

Completed
Phase of Trial: Phase IV

Latest Information Update: 27 Oct 2014

At a glance

  • Drugs Lamotrigine (Primary)
  • Indications Epilepsy
  • Focus Adverse reactions
  • Acronyms EUROCAT
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 29 Sep 2014 Trial status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
    • 31 Aug 2012 Planned number of patients (1) added as reported by ClinicalTrials.gov record.
    • 03 Feb 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top